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rain abscess, epidemiology, clinical manifestations and man-
gement
. Abbasi1, M. Besharat2, S. Korooni3,∗
Bushehr University ofMedical sciences, Bushehr, Iran, Islamic Repub-
ic of
Shahid Beheshti Medical University, Tehran, Iran, Islamic Republic of
Shiraz University of medical Sciences, Shiraz, Iran, Islamic Republic
f
Background: Infection involving the cerebrum is a true neuro-
urgical emergency that requires rapid diagnosis and appropriate
urgical andmedical intervention to achieve good clinical outcome.
Methods: In this study we evaluated 41 pateints with brain
bscess in our hospital in during 2005-2010. Demographic infor-
ation, predisposing factors, clinical manifestations, lab. data and
anagements were evaluated.
Results: In this study%53.6of patientswere15-29years old, %26
ere 30-49 and %17 were 50-70 years old. Clinical manifestation
as as follow in our study:
Headache %92.6, nausea and vomiting %73.1, meningeal signs
17, drowsiness %12, decreased level of consciousness %9.7, fever
9.7, uninary and fecal incontinency % 7.3, visual disturbance % 7.3,
hills %4.8. Predisposing condition leading to brain abscess in our
tudy were sinusitis in %9.17, otitis in % 12, CSF rhinorrhea in %
.4, mastoiditis in % 7.2, neurosurgery in % 17 and endocaiditis in
2.4. %20 of our patients had no risk factor. Antibiotics used in our
tudy were ceftriaxne, metronidazole and vancomycin. Mortality
ate was %12 in this study. % 9.7 of our patient that were admitted
ith diagnosis of brain abscess ﬁnally diagnosed as they had acute
emyelinating encephalomyelitis (ADEM).
Conclusion: With promp diagnosis and treatment most cases
f brain abscess survived. Few cases initially diagnosed as brain
bscess may have other diagnosis like acute demyelinating
ncephalomyelitis (ADEM).
ttp://dx.doi.org/10.1016/j.ijid.2012.05.834
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long–term antimicrobial prophylaxis and/or immunotherapy
n female patients with recurrent urinary tract infections
. Krcmery1,∗, J. Hromec2
Comenius University Faculty of Medicine, Bratislava, Slovakia
University of Trnava, Trnava, SlovakiaBackground: It is accepted that long-term low-dose antimicro-
ial prophylaxis decreases recurrence of urinary tract infections
UTI). In recent years, the oral administration of immunother-fectious Diseases 16S (2012) e158–e316
apeutic agents has been considered as an alternative approach.
The objective of this multicenter study was to investigate the
long–term preventive effect of chemoprophylaxis with low-dose
ﬂuoroquinolones and/or immunotherapy inwomenwith recurrent
UTI. Both Uro–Vaxom (OM–89) and Luivac are extracts of bacterial
components with complex immunostimulating activity.
Methods: Adult female patients with at least 3 documented
episodes of UTI in previous year were enrolled in this 12-months,
multicenter study. Patients received continuous chemoprophylaxis
with low–dose ciproﬂoxacin and/or immunotherapy with either
Uro-Vaxom or Luivac. Primary efﬁcacy criteria were UTI episodes
over the 12 months treatment period.
Results: A total of 178 patients were treated, 89 in the
Uro–Vaxom and 89 in the Luivac group, respectively. Mean
rate of post baseline UTIs decreased signiﬁcantly in both
treatment groups: in Uro–Vaxom group from 3.54 to 0.48
episode/patient/year and in Luivac group from 3.63 to 0.41
episode/patient/year, p <0.001. There were 67.1% patients treated
with combination of immunotherapy and quinolone prophylaxis
vs. 52.7% patients treated with immunotherapy only, who were
UTI–free in 12–months study period (p=0.04). In the subgroup
receiving continuous antimicrobial prophylaxis with ciproﬂoxacin
(125mg orally every other day), selection of quinolone-resistant
strainswas observed in 9 patients (ESBL–producing strains of E. coli
and Klebsiella pneumoniae).
Conclusion: These results conﬁrm that immunotherapy ismore
safe and almost as effective as low-dose quinolone prophylaxis
in prevention of recurrent UTI. Selection of quinolone–resistant
strains is a potential threat for patients on long-term treatment
with ﬂuoroquinolones.
http://dx.doi.org/10.1016/j.ijid.2012.05.835
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Multilocus sequencing analysis of viridans group streptococci
isolated from patients with infective endocarditis
N. Kumar ∗, T. Menon
Dr.ALM PG IBMS University of madras, Chennai, Tamilnadu, India
Background: Infective endocarditis (IE) is a serious infection
associated with considerable morbidity and mortality. About 44%
of the IE cases are commonly due to a heterogeneous group of
organisms, which are the part of commensal ﬂora of the upper res-
piratory tract in humans called viridans group streptococci (VGS).
Each species of VGS possesses variable pathogenicity and viru-
lence potential, hence, accurate identiﬁcation of VGS to the species
level is important. The taxonomy of these organisms has been
always perplexing, and accurate identiﬁcation of VGS remains a
challenge due to the high degree of similarity between members
of the groups. Very closely related species of VGS can be identiﬁed
from other species using the concatenated sequences of multiple
core (house-keeping) genes known asMultilocus Sequencing Anal-
ysis (MLSA). More recently, a MLSA technique has been developed
for identiﬁcation of VGS based on the nucleotide sequence analy-
sis of seven house-keeping genes. Hence, this study was aimed to
assess the reliability and discriminate efﬁciency of MLSA for the
identiﬁcation of VGS.
